Cancer drugs may remain approved despite lack of benefit

In the United States, cancer drugs are sometimes approved through sped-up processes - and they often stay approved even if later studies show them to be inferior to other options or even worse than doing nothing, a new study found.

 

Read the full article here.

Tags:

Please reload

Please reload

© 2016 by The National Center for Health Research. 

  • Facebook Clean
  • Twitter Clean